👋 We are very pleased and honored to announce that Jeroen Aerssens, PhD has joined Rejuvenate Biomed as Chief Development Officer. Jeroen brings a wealth of experience in pharmaceutical R&D, encompassing preclinical drug discovery, translational research and clinical development. With over 25 years in pharma, he has a proven track record in building and leading research teams in the field of biomarkers and clinical translational science. 🚀 “We are delighted to welcome Jeroen to our team! His exceptional expertise in drug discovery and development will be instrumental in propelling our mission of pioneering innovative solutions for healthy aging. With Jeroen on board, our leadership will enhance our capabilities and drive our mission forward. We are confident that his leadership will support in scaling our operations and explore new development opportunities”, Ann Belien, PhD, Founder & CEO of Rejuvenate Biomed https://lnkd.in/eKtWJZSd #healthyaging #biotech #teamwork #growingcompany #leadership #healthinnovation #lifesciences
Rejuvenate Biomed
Biotechnology Research
Diepenbeek, Flemish Region 2,365 followers
We envision a future where people stay healthy for life
About us
Rejuvenate Biomed is a clinical-stage company dedicated to the discovery and development of therapeutics to prevent or delay the onset of multiple age-related diseases. Founded in 2017, Rejuvenate Biomed is a privately-held platform and pipeline company developing safe and proprietary combination drugs that help people healthy for life. By using platform technologies, Rejuvenate Biomed identifies safe compounds that influence the aging process. Novel combination drugs are discovered that have the potential to prevent or delay the onset of multiple age-related diseases. Rejuvenate Biomed confirms prediction data in preclinical models and in clinical studies. Rejuvenate Biomed’s lead drug candidate RJx-01 is currently in Phase 1b for the treatment of sarcopenia, the progressive age-associated loss of muscle function and mass.
- Website
-
https://www.rejuvenatebiomed.com/en
External link for Rejuvenate Biomed
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Diepenbeek, Flemish Region
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Healthcare, Healthspan, Aging, Mouse, Sarcopenia, C. elegans, Research, Drug development, Drug discovery, and Clinical trials
Locations
-
Primary
Wetenschapspark 13
Diepenbeek, Flemish Region 3590, BE
-
One Broadway
Cambridge, MA 02142, US
Employees at Rejuvenate Biomed
-
Glenn Van Dael
Managing Partner | Life Sciences & Healthcare | Consultancy - Digital - PM | @ Phoenx
-
Ann Belien, PhD
Founder and CEO of Rejuvenate Biomed | Translating Fundamental Insights into Healthy Aging Therapies
-
Annick Van Nijverseel
freelance management assistant Biotech/Pharma - bringing your organization to the next level, sustainable for the future, providing the right support…
-
Rene Kerstens
Senior Biostatistician - Owner Orion*** Statistical Consulting
Updates
-
Our colleague Dr. Jens Frickel is attending & presenting at the Data Science for Planetary and Human Health conference, in Copenhagen, 10-12 June https://lnkd.in/eFua2v4x 🌍💡 Looking forward to discuss and discover the latest developments in the field of data science, data management, and communication. We are also proud to announce that Jens has been selected for a poster session! 🎉 If you are at the conference, make sure to stop by poster 73 to learn more about the innovative work happening at Rejuvenate Biomed #RejuvenateBiomed #DataScience #HealthInnovation #CopenhagenConference #Sciencecluster
-
-
Rejuvenate Biomed is really excited to bring first sarcopenia patient data to our meetings at BIO in San Diego. Discover how our novel approach to age-related diseases can make a difference in keeping people healthy as long as possible. 🚩 Let's connect in the BIO One-on-One Partnering tool and meet Frederic Godderis, Chief Strategy Officer, Lizzy-Anne (Lisiane) Neven, CFO and Dr. Ann Belien, Founder & CEO. 👉 Follow our company presentation on Monday June 3rd at 3:15pm local time in Theater 4. Looking forward to connecting with you during the week. 🌟 #BIO2024 #Biotech #InvestorEngagement #businessdevelopment #healthyaging
-
-
🌟 A heartfelt thank you to flanders.bio for the fabulous edition of 20 years FlandersBio at #kfg2024. 🌟 Rejuvenate Biomed, represented by Lizzy-Anne (Lisiane) Neven, was honored to be among such esteemed organizations & companies from both the Belgian and international health ecosystem. 🎯 We are dedicated to pioneering innovative solutions for healthy aging, and events like this inspire us to push boundaries even further. Delighted to also connect here with our colleagues from Limburg: Health Campus Limburg DC, POM Limburg, BioVille, Arnold & Siedsma and many others. 🎉 Here's to many more years of innovation, collaboration and celebrating life sciences! #knowledgeforgrowth #kfg2024 #flandersbio #healthyaging
-
-
📣 Rejuvenate Biomed is #hiring: Lead Scientist, location Diepenbeek, Health Campus Limburg DC 💡 Join us in our fit for purpose: we envision a future where people stay healthy for life. You become part of an ambitious clinical-stage biotech company dedicated to the discovery and development of therapeutics to delay the onset of multiple age-related diseases. ⭐ We are a dedicated team where expertise, focus and friendship is key. If you are a dedicated scientist with a passion for aging research and the expertise to lead a dynamic research team, send your CV and motivation letter 👉 [email protected] www.rejuvenatebiomed.com #aging #biotech #diepenbeek #scientist #discovery
-
Rejuvenate Biomed is gearing up to make a splash at #BioEquityEurope Conference in the beautiful San Sebastián on May 12-14. Dr Ann Beliën, Founder & CEO, is taking center stage and will unveil the exciting muscle strength data from our latest clinical trial on Tuesday May 14th, at 2pm, in room 6 7. We're eager to collaborate and explore funding opportunities. Share your interest and book a one-on-one meeting for a fruitful exchange of ideas and insights. Let's shape the future of healthcare together! 🤝 See you there! #musclestrength #clinicaltrial #biotech #funding
-
-
🤝 Let us meet at #partnering LSX World Congress in London (29-30 April) 📢 Looking forward to present this Monday at 14:45 local time the progress we made as a company: first compound in the clinic, multiple preclinical assets identified, and our platforms clinical validated 🎯 Our mission is to ensure lifelong health for all patients by developing innovative therapeutics that target the root causes of age-related diseases ✔ We are open for further collaborations and looking for investments LSX World Congress #fundraising #biotech #partnership #investments
-
-
👋 We're thrilled to welcome Dr. Nick Smisdom to the Rejuvenate Biomed team as our new Senior DevOps Engineer and Data Architect! With his expertise in managing large data volumes and integrating diverse datasets within scientific settings, Nick will drive the development of performant and scalable data solutions to support our cloud-native and data-intensive research. His dedication to data integrity and governance aligns seamlessly with our commitment to quality and compliance. Here's to advancing drug discovery through high-throughput biology and artificial intelligence with Nick on board! 🚀 #welcometotheteam #dataexpert #companygrowth #biotech #innovation
-
-
We will proudly present the key results from our Phase 1b #clinicaltrial in #sarcopenia at this year's World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases. Stay tuned for the latest advancements in improving musculoskeletal health: https://ow.ly/xLlE50R6AEQ #conference #biotech #aging
-
-
Many thanks #hevolutionfoundation for your continued support of our mission 🙏 #healthyaging #clinicalstage #teamwork
As a physician and a daughter, witnessing her father aging, Dr. Ann Belien, PhD, is driven by personal and professional motivation to translate basic science insights into healthy #aging therapies at her preclinical company, Rejuvenate Biomed. We were delighted to host Dr. Ann at the #GlobalHealthspanSummit to share Rejuvenate Biomed's approach. Watch the panel discussion here: https://lnkd.in/du3E6MsT #health #biotech #AI #datascience #healthspan #lifespan #science #Hevolution #clinical #research